Needham Reiterates Buy on Pulse Biosciences
Bullish, based on the analyst’s rating and target; confidence is limited because no new company-specific catalyst is provided.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish, based on the analyst’s rating and target; confidence is limited because no new company-specific catalyst is provided.
What happened, with direct paths to the underlying reporting
Needham reiterated its Buy rating on PLSE with a $64 target versus a posted price of $45.12, indicating meaningful analyst-estimated upside. The target remains an opinion rather than a confirmed catalyst.
Target: $64
Posted price: $45.12
Analyst firm: Needham
Analyst: Mike Matson
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.